Tag: supply

REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced positive topline results from a confirmatory efficacy study comparing AVT23 (ADL-018), a proposed biosimilar to Xolair® (omalizumab), with the reference biologic.

Innovative needle-free technology empowers users to monitor glucose signals, oxygen saturation, and heart rate from home—without the discomfort or complexity of traditional tools.

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Swiss Water Decaffeinated Coffee Inc. (TSX:SWP) (“Swiss Water” or the “Company”) is pleased to announce it has successfully completed the renewal and amendment (the “Amended Revolving Facility”) of its existing revolving credit facility resulting in an $80 million revolving credit facility. The Amended Revolving Facility provides the Company with $35 million of incremental borrowing capacity, consisting of $10 million of expanded revolving credit capacity with CIBC and the introduction of $25 million of incremental revolving credit capacity with Rabobank. The Amended Revolving Facility has a maturity date of June 23, 2027, and replaces the Company's current credit facilities with CIBC, which matures on October 19, 2025. The new agreement includes an option to extend maturity by one year, to June 23, 2028.